Medline Inc. is 41.8x more valuable than KESTRA MEDICAL TECHNOLOGIES, LTD. by market capitalization ($49.12 B vs $1.18 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | KMTS | MDLN |
|---|---|---|
| Market cap | $1.18 B | $49.12 B |
| US-listed rank | #2530 | #322 |
| Revenue (latest FY) | $59.81M | $28.43B |
| Net income (latest FY) | -$113.81M | $1.16T |
| Net margin | -190.3% | 4069.4% |
| P/E (trailing FY) | - | 0.0 |
| SEC filings | 105 | 103 |
Medline Inc. is 41.8x more valuable than KESTRA MEDICAL TECHNOLOGIES, LTD. by market capitalization ($49.12 B vs $1.18 B).
In their latest fiscal years, KESTRA MEDICAL TECHNOLOGIES, LTD. reported $59.81M in revenue while Medline Inc. reported $28.43B.
Full pages: KESTRA MEDICAL TECHNOLOGIES, LTD. and Medline Inc., or browse the full rankings.